Navigation Links
New Data Suggest Cymbalta(R) Reduced Pain in Fibromyalgia Patients With and Without Depression
Date:8/21/2007

ents should call their doctor right away if they experience worsening depression symptoms, unusual changes in behavior or thoughts of suicide. Be especially observant within the first few months of treatment or after a change in dose. Cymbalta is approved only for adults 18 and over.

Cymbalta is not for everyone. Patients should not take Cymbalta if they have recently taken a type of antidepressant called a monoamine oxidase inhibitor (MAOI), are taking Mellaril(R) (thioridazine) or have uncontrolled glaucoma. Patients should speak with their doctor about all medicines they are taking, including those for migraine, to avoid a potentially life-threatening condition. Patients should tell their doctor about their alcohol consumption, if they have liver disease, and about all of their medical conditions.

Patients taking Cymbalta may experience dizziness or fainting upon standing. The most common side effects of Cymbalta include:

-- For MDD: Nausea, dry mouth and constipation

-- For DPNP: Nausea, somnolence (sleepiness), dizziness and constipation

-- For GAD: Nausea, fatigue, dry mouth, somnolence (sleepiness) and

constipation

This is not a complete list of side effects.

For full Patient Information, visit http://www.cymbalta.com.

For full Prescribing Information, including Boxed Warning, visit http://www.cymbalta.com.

About Eli Lilly and Company

Lilly, a leading innovation-driven corporation, is developing a growing portfolio of first-in-class and best-in-class pharmaceutical products by applying the latest research from its own worldwide laboratories and from collaborations with eminent scientific organizations. Headquartered in Indianapolis, Ind., Lilly provides answers - through medicines and information - for some of the world's most urgent medical needs. Additional information about Lilly is
'/>"/>

SOURCE Eli Lilly and Company

Copyright©2007 PR Newswire.

Page: 1 2 3 4 5

Related medicine technology :

1. Clinical Data Suggest Decreased Bleeding Risk in People With Severe Hemophilia A While Maintaining Factor VIII Levels Above One Percent
2. Samaritans Alzheimers Drug Caprospinol Suggests Brain May be Able to Heal From Alzheimers Disease
3. Beike Biotechnology Study Suggests Adult Stem Cells Show Promise for Peripheral Vascular Disease
4. New Study in Journal of Pediatrics Suggests Synagis (Palivizumab) May Reduce Subsequent Recurrent Wheezing in Preterm Infants
5. Clinical Trial Suggests Bone Marrow Stem Cells Are Useful for Spinal Cord Injury; PrimeCell Therapeutics Provided Pre-Clinical Study
6. Resveratrol Studies Suggest Broad Implications for SIRT1 Activation in Neurodegenerative Diseases of Aging Such as Alzheimers Disease
7. Second Successful Quigley QR-443 Study Suggests Method of Action Relevant to Broad Range of Chronic Inflammatory Diseases - Human Study to Follow -
8. Three Studies Suggest Abbotts Humira (adalimumab) May Improve Work Productivity in Patients with Rheumatoid Arthritis
9. New Study Suggests Better Patient Outcomes with CYPHER Sirolimus-Eluting Coronary Stent than with Taxus Stent in Real-World Clinical Settings
10. Study Suggests Strattera Improved ADHD Symptoms in Patients With Comorbid Alcohol Abuse
11. New Study Suggests no Significant Impairment in Middle-of-the-Night Balance, Mobility or Memory in Older Adults Using Ramelteon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2014)... -- Juno Therapeutics today announced that the FDA ... JCAR015 chimeric antigen receptor product candidate.  The designation ... B-cell acute lymphoblastic leukemia and was filed by ... where Phase 1 clinical trials are currently underway. ... news for patients who may benefit from the ...
(Date:11/24/2014)... Nov. 24, 2014 Luoxis Diagnostics, Inc., ... AMPE), today announced the presentation of three clinical ... as a broadly applicable and robust research tool ... body in response to injury, illness, or stress.  ... collaboration with Luoxis, academic and pharmaceutical research partners, ...
(Date:11/24/2014)... Nov. 24, 2014  Relmada Therapeutics, Inc. (OTCQB: RLMD), ... of chronic pain, announced today that Sergio Traversa ... the LD MICRO "MAIN Event" Micro-Cap Growth Conference on ... at the Luxe Sunset Bel Air Hotel, which is ... Angeles, California . The presentation is ...
Breaking Medicine Technology:Juno T Cell Therapy For Leukemia Granted FDA Breakthrough Therapy Designation 2Juno T Cell Therapy For Leukemia Granted FDA Breakthrough Therapy Designation 3Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 2Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 3Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 4Luoxis Announces Presentation of Multiple Studies Validating RedoxSYS as a Rapid and Non-invasive Means of Assessing Oxidative Stress 5Relmada Therapeutics To Present At LD MICRO Conference 2
... Oct. 31, 2011 Covance Inc. (NYSE: ... ranked first, by a wide margin, in an independent ... trials. The majority (54 percent) of the study participants ... central laboratory, with investigators citing Covance three times more ...
... InterMune, Inc. (NASDAQ: ITMN ) today ... Shire plc, has been appointed to InterMune,s Board of ... on meeting the needs of the specialist physician. ... a leading global biopharmaceutical company with expertise in the ...
Cached Medicine Technology:Covance Central Laboratory Services Ranks #1 in Global Investigator Satisfaction Survey 2Covance Central Laboratory Services Ranks #1 in Global Investigator Satisfaction Survey 3InterMune Appoints Angus C. Russell to Board of Directors 2InterMune Appoints Angus C. Russell to Board of Directors 3
(Date:11/24/2014)... From embedded sensors and biometrics to elite training and ... center stage at the FitnessTech Summit , presented by ... International CES® , January 6, 2015 in Las Vegas (8:30am ... bond between fitness and technology is stronger than ever as ... about the human body. , “Fitness technology has become a ...
(Date:11/24/2014)... PA (PRWEB) November 24, 2014 ... Nataliya Ternopolska, MD has joined The Neurology Group ... Health’s Multiple Sclerosis Center. , A graduate of ... in Neurology at Albert Einstein Medical Center in Philadelphia ... Judith Jaffe Multiple Sclerosis Center at Weill Cornell Medical ...
(Date:11/24/2014)... November 24, 2014 The Holiday Inn ... Family and Children's Association to donate various ... shampoo, mouthwash and other such items.The Association's program is ... home bound, living in nursing homes, assisted living facilities ... enhance the well being of seniors throughout the Long ...
(Date:11/24/2014)... Longmont, CO, and Philadelphia, PA (PRWEB) November 24, ... a provider of care coordination and disease management ... organizations, has chosen to implement Essette’s Medical Management ... powerful new Essette SaaS platform in a program ... latest Essette suite includes Population Health Management, Care ...
(Date:11/23/2014)... a well-known wedding dress manufacturer, has unveiled its new collection ... now offered at deeply discounted prices, up to 75 percent ... 15. The main purpose of the promotion is to expand ... are ideal options for ladies who are eager to look ... new mint cocktail dresses are very beautiful; they are made ...
Breaking Medicine News(10 mins):Health News:Next Wave Fitness Products Debut at FitnessTech Summit Living in Digital Times at the 2015 International CES 2Health News:Next Wave Fitness Products Debut at FitnessTech Summit Living in Digital Times at the 2015 International CES 3Health News:Next Wave Fitness Products Debut at FitnessTech Summit Living in Digital Times at the 2015 International CES 4Health News:Nataliya Ternopolska Named Associate Medical Director of Abington Health’s Multiple Sclerosis Center 2Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 2Health News:The Holiday Inn Westbury - Long Island gives back to the local Long Island community, and also goes beyond borders to assist those in need during the 2014 Holiday Season 3Health News:ReAdmission Solutions, LLC Selects Essette 2Health News:Trendy Long Black Evening Gowns Now Provided By iFitDress.com 2
... another incentive for individuals to maintain a healthy weight. The ... is// associated with a poorer quality of life in older ... there have been dramatic improvements in life expectancy. Meanwhile, the ... increase. Will this excess weight have an impact on individuals ...
... a molecule that stops the growth of the AIDS virus in ... ,Researchers say alpha-1 antitrypsin (AAT) -- a protein in the ... cells to grow, they must be in an active state. They ... off from the hard drive.” ,Previous research has shown ...
... you have lower back pain, the right mattress can make ... a firm bed mattress, but a new study says they ... more effective at relieving back pain. ,Physicians often ... is best for their lower back pain. Few studies have ...
... you were when you heard about the World Trade Center ... forget. But why? A new study finds lasting memories are ... protein kinase C.// ,Researchers from Wake Forest University Baptist ... of the Society of Neuroscience in New Orleans. Researchers say ...
... A new, safe, and promising therapy option may be more ... rosacea, a chronic skin disease that causes persistent redness on ... of azelaic acid gel to the faces of rosacea sufferers. ... specifically made for rosacea. Typically it has a different formula ...
... The number of cases of diabetes in developing countries ... next 30 years, from 115 million in 2000 to ... Day, 14 November, 2003, with a commitment to increase ... its complications, particularly among low- and middle-income communities, in ...
Cached Medicine News:Health News:Excess Weight Can Affect Individuals as They Age 2Health News:Diabetes cases could double in developing countries in next 30 years 2
TBR-720-2-GD is large capacity upright style operating temperature +4C. It is specially designed refrigerators for the storage of blood in standard 500ml bags, complying with Australian Standard AS38...
... direct competitive EIA for the quantitative ... or plasma. A specific agent displaces ... available for antibody binding. Testosterone then ... to fluorescein isothiocyanate (FITC) and alkaline ...
... Testosterone, (17-Hydroxy-4-androstene-3-one), a C19 steroid, is one ... [1]. In postpubertal males, testosterone is secreted ... small amount derived from peripheral conversion of ... been estimated that over 50% of serum ...
... testosterone exists as unbound or free testosterone. ... SHBG with high affinity [1], while the ... the albumin-bound and free fractions may be ... action. Measurement of the free or unbound ...
Medicine Products: